|1.||Kutner, Andrzej: 15 articles (01/2015 - 01/2002)|
|2.||Wietrzyk, Joanna: 9 articles (01/2015 - 09/2004)|
|3.||Milczarek, Magdalena: 5 articles (08/2014 - 10/2008)|
|4.||Ishikawa, Osamu: 5 articles (08/2010 - 02/2005)|
|5.||Abe, Masatoshi: 4 articles (08/2010 - 02/2005)|
|6.||Opolski, Adam: 4 articles (04/2007 - 09/2004)|
|7.||Maciejewska, Magdalena: 3 articles (02/2013 - 10/2008)|
|8.||Yokoyama, Yoko: 3 articles (08/2010 - 02/2006)|
|9.||Sogabe, Yoko: 3 articles (01/2008 - 02/2005)|
|10.||Budziszewska, Bogusława: 3 articles (07/2007 - 03/2005)|
|1.||Psoriasis (Pustulosis Palmaris et Plantaris)
07/01/2005 - "Tacalcitol was highly effective in the symptomatic treatment of moderate psoriasis. "
02/01/2004 - "The results of this study indicate that topical application of tacalcitol (4 micro g/g) emulsion once daily is an effective, safe and very well- tolerated treatment for scalp psoriasis."
01/01/2009 - "Treatment with tacalcitol ointment may be useful to treat nail psoriasis as it achieves a significant improvement in all nail parameters, both of the matrix and of the bed."
02/01/2004 - "Tacalcitol was significantly superior to placebo in reducing the severity of scalp psoriasis. "
09/01/2002 - "Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris."
12/01/2006 - "To study and compare the efficacy of combined 308-nm monochromatic excimer light (MEL) therapy with tacalcitol vs. that of MEL 308-nm therapy alone in treatment of vitiligo. "
02/01/2009 - "Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo."
12/01/2006 - "Our results have shown that concurrent topical tacalcitol potentiates the efficacy of the 308-nm MEL in the treatment of vitiligo, and that this combination achieves earlier pigmentation with a lower total dosage."
03/01/2006 - "Addition of topical tacalcitol to NB-UVB treatment improved the extent of repigmentation and increased the response rate in patients with vitiligo compared with NB-UVB treatment alone. "
09/01/2012 - "Freckling promoted by topical tacalcitol in a Japanese boy with left eyelid vitiligo."
07/01/2003 - "In this study, tacalcitol ointment (20 micro g/g) was found to have a marked effect on cutaneous inflammation and improved effect on epidermal differentiation, although tacalcitol ointment (2 micro g/g) also had significant effects on epidermal proliferation and differentiation. "
03/01/2004 - "In this study, tacalcitol was found to have an inhibitory effect on cutaneous inflammation such as inhibition of neutrophil infiltration, MIP-2 and KC production, and mast cell degranulation in TPA-treated hairless mice. "
06/01/2010 - "These findings suggest that tacalcitol reduces skin inflammation by partially downregulating CLA expression levels."
07/01/2003 - "Tacalcitol ointment (0, 2 and 20 micro g/g) significantly inhibited 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced cutaneous inflammation, histopathologically. "
07/01/2003 - "Pharmacological profiles of high-concentration (20 microg/g) tacalcitol ointment: effects on cutaneous inflammation, epidermal proliferation, and differentiation in mice."
|4.||X-Linked Ichthyosis (Ichthyosis, X Linked)
|5.||Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris)
|5.||Coal Tar (Estar)
|8.||Cholecalciferol (Vitamin D3)
|9.||betamethasone-17,21-dipropionate (betamethasone dipropionate)
|2.||Phototherapy (Light Therapy)
|4.||Photochemotherapy (Photodynamic Therapy)
|5.||Occlusive Dressings (Occlusive Dressing)